Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_assertion description "[While observed no correlation between ephrin ligand expression and clinical outcome in microarray datasets, ephrin-A1 and EphA2 protein co-expression was significantly associated with recurrence in Stage I prognostic breast cancer TMAs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_assertion evidence source_evidence_literature NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_assertion SIO_000772 21935409 NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_assertion wasDerivedFrom befree-20140225 NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_assertion wasGeneratedBy ECO_0000203 NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP286524.RAvBZtsYQ9IKFEDWr-AyjCyMfas8oA7dL3BipcY6F9GnY130_provenance.